News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 217–252
- Matches
- 399
- Sources here
- 17
- Companies here
- 12
Active search
399 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
NBP|Novabridge Biosciences ADR|Price:1.770|
This article provides a financial overview of Novabridge Biosciences ADR (NBP), presenting its key financial indicators, income statement, balance sheet, and cash flow statement. It details quarterly and annual performance data, including EPS, revenue, net profit, assets, liabilities, and equity for FY2025. The report …
ALOV|Aldabra 4 Liquidity Opportunity Vehicle Units|Price:9.960|Chg%:-0.020
This article provides a detailed profile of Aldabra 4 Liquidity Opportunity Vehicle Units (ALOV), an investment holding company. It includes key financial data such as its market cap and current price, along with company details like its IPO date, CEO, address, and executive team. …
Fabrinet (FN) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Fabrinet (FN), outlining its major institutional holders and the types of shareholders. It provides specific percentages for top holders like BlackRock and T. Rowe Price, categorizes shareholder types, and tracks institutional shareholding changes over recent quarters. Additionally, …
Novabridge Biosciences ADR (NBP) Valuation: PE, PB & Fair Value Analysis
This article provides a brief overview of Novabridge Biosciences ADR (NBP) stock performance and its market capitalization. It highlights the stock's closing price, recent change, and indicates that it is currently trading in pre-market. The page seems to be a gateway to more detailed …
Is Contract-Driven Revenue Uncertainty Altering The Investment Case For Fabrinet’s FN Options Traders?
Fabrinet (FN) is facing increased scrutiny from analysts regarding contract structures, which could affect near-term revenue visibility, coupled with a spike in volatility for long-dated call options indicating investor caution. The company's investment narrative focuses on its role in high-speed optical and AI infrastructure, …
Sei Investments Co. Increases Holdings in Fabrinet $FN
Sei Investments Co. increased its stake in Fabrinet (FN) by 22% in the first quarter of 2026, reaching a total of 89,843 shares valued at approximately $46.9 million. This increase follows Fabrinet's strong quarterly earnings, where the company exceeded analyst expectations with an EPS …
Maxim Group Initiates Cyabra(CYAB.US) With Buy Rating, Announces Target Price $1
Maxim Group has initiated coverage on Cyabra (CYAB.US) with a "Buy" rating. The investment bank has also set a target price of $1 for the company's stock. This new coverage suggests a positive outlook from Maxim Group regarding Cyabra's future performance.
NovaBridge to Hold 2026 Annual Shareholders Meeting
NovaBridge Biosciences will conduct its 2026 annual general meeting in Shanghai on September 8, 2026, where shareholders of record as of July 27, 2026, will vote on the company's future. The company recently filed its 2025 annual report with the SEC and highlighted its …
Seabridge Gold, Inc. Revenue Breakdown – BOATS:SA
The article provides a detailed breakdown of Seabridge Gold, Inc.'s financial information, specifically focusing on its revenue and segmental performance. It offers various fundamental and statistical data, including statements, statistics, dividends, earnings, and insights into top segments and regional performance. The information is presented …
Fabrinet (FAN) Q4 2023 Earnings Report - Results, Call & Slides
This report details Fabrinet's (FAN) Q4 2023 earnings, showing the company beat both EPS and revenue expectations. Actual EPS was €1.63 against a consensus of €1.58, and actual revenue was €576.05M against an expected €563.36M, marking an 11.57% YoY revenue growth. The report also …
ADS Holders Must Use Citibank to Vote at NovaBridge AGM
NovaBridge Biosciences (Nasdaq: NBP) will hold its Annual General Meeting (AGM) on September 8, 2026, at 10:00 a.m. Shanghai time, at its Shanghai office. Shareholders of record as of July 27, 2026, are eligible to vote, with American Depositary Share (ADS) holders required to …
NovaBridge Biosciences schedules AGM for Sept 8, 2026, highlighting progress in cancer and retinal disease drug development.
NovaBridge Biosciences has scheduled its annual general meeting (AGM) for September 8, 2026, in Shanghai. The company will discuss its 2025 financial report and strategic plans, while also highlighting progress in clinical-stage biopharmaceutical treatments. These include givastomig for gastric cancer and VIS-101 for retinal …
NovaBridge Biosciences (Nasdaq: NBP) schedules AGM to vote on director removal
NovaBridge Biosciences (Nasdaq: NBP) has scheduled an Annual General Meeting for September 8, 2026, in Shanghai, to vote on a resolution to remove Ms. Xin Liu as a director. The company's board recommends voting "FOR" the resolution, citing efforts to improve corporate governance and …
Arbor Realty Trust Schedules Second Quarter 2026 Earnings Conference Call
Arbor Realty Trust UNIONDALE, N.Y., July 24, 2026 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE: ABR), today announced that it is scheduled to release second quarter 2026 financial results before the market opens on Friday, July 31, 2026. The Company will host a …
Why Fabrinet Is Dropping 5.6%: Needham Maintains Buy
Fabrinet shares dropped 5.6% after Needham cut its price target by 18.8% to $650 from $800, despite maintaining a Buy rating. The significant reduction in the price target, attributed to product contract concerns, indicates a weakening conviction in the optical components manufacturer. Investors are …
126,500 Shares in Sabra Healthcare REIT, Inc. $SBRA Purchased by Mizuho Markets Americas LLC
Mizuho Markets Americas LLC recently purchased 126,500 shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) valued at approximately $2.43 million, establishing a new position in the company. Other institutional investors also adjusted their holdings in the REIT. Despite mixed analyst ratings, the consensus remains a …
Bowen Hanes & Co. Inc. Has $51.48 Million Stock Position in Fabrinet $FN
Bowen Hanes & Co. Inc. significantly increased its stake in Fabrinet (NYSE:FN) by 97.4% in the first quarter, now holding 98,715 shares valued at approximately $51.48 million. Fabrinet reported strong Q1 results, surpassing EPS and revenue estimates, with revenue growing 39.3% year-over-year. Despite some …
Militia Capital Management LLC Buys Shares of 46,000 Sabra Healthcare REIT, Inc. $SBRA
Militia Capital Management LLC has acquired 46,000 shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA), valued at approximately $885,000, initiating a new position in the company during the first quarter. This investment comes as Sabra Healthcare REIT reported Q1 EPS of $0.16 on $211.74 million …
Sabra Health Care REIT scales tested technologies across portfolio
Sabra Health Care REIT is expanding the use of successful pilot-tested technologies across its portfolio, as detailed in its sixth annual sustainability report. This initiative, part of a sustainability roadmap launched in 2021, focuses on practical innovations to strengthen communities and the portfolio long-term. …
Fabrinet (FN) Falls 17% In A Month, Is It Cheap Or Fully Valued?
Fabrinet (FN) has seen a 17% stock price drop in the last month, despite strong long-term performance. While a common valuation narrative suggests it's 19.1% undervalued with a fair value of $635, a discounted cash flow model suggests it’s trading above its intrinsic value …
Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report
Sabra Health Care REIT, Inc. has released its sixth annual Sustainability Report for fiscal year 2025, detailing its progress in integrating sustainability into its business strategy. The report highlights the company's efforts to scale successful pilot technologies into portfolio-wide initiatives, focusing on improving care …
Sabre announces upcoming webcast of its second quarter 2026 earnings conference call
Sabre Corporation will host a live webcast of its second quarter 2026 earnings conference call on August 6, 2026, at 9:00 a.m. ET. Management will discuss financial results and provide a forward outlook. The webcast will be available on the Investor Relations section of …
CYABRA, INC. (CYAB) reports $6.0M sold in exempt securities deal
CYABRA, INC. (CYAB), based in Tel Aviv, has filed a Form D for an exempt private securities offering under Rule 506(b) of Regulation D, having sold $6,009,901 USD in equity and warrants as of July 10, 2026. The company intends to sell an additional …
How Investors Are Reacting To Sabra Health Care REIT (SBRA) Re-Tenanting Avamere Portfolio To Boost Cash NOI
Sabra Health Care REIT (SBRA) recently announced the re-tenanting of 26 Avamere-leased properties, primarily to Cascadia Healthcare subsidiaries, a move expected to increase annualized cash NOI by over US$9 million and lift its 2026 full-year guidance. This transition is projected to boost annualized cash …